Investigation on the factors associated with maintenance of paliperidone long-acting injection in the real-world treatment of patients with schizophrenia
The findings highlight the importance of adhering to the standard dosing regimen for PLAI initiation and its potential as an augmentation agent in combination with other antipsychotics. Initiating PLAI in an outpatient setting and addressing adherence challenges early in treatment may enhance long-term treatment continuity in patients with schizophrenia.
Authors
- Sung Woo Joo (ORCID: https://orcid.org/0000-0001-6555-9110)
- Joongyub Lee (ORCID: https://orcid.org/0000-0003-2784-3772)
- Nuree Kang (ORCID: https://orcid.org/0000-0001-7630-4033)
- Kyu Young Lee (ORCID: https://orcid.org/0000-0003-3214-6082)
- Aejeong Jo (ORCID: https://orcid.org/0000-0003-1228-7021)
- Jeonghoon Lee (ORCID: https://orcid.org/0009-0003-8283-5780)
- Yong Sik Kim (ORCID: https://orcid.org/0000-0002-8845-5186)
- Jae Hoon Jeong
- Se Hyun Kim (ORCID: https://orcid.org/0000-0001-7078-2835)
- Jung Sun Lee (ORCID: https://orcid.org/0000-0002-9245-8603)
Institutions
- Gyeongguk National University (KR)
- Ulsan College (KR)
- Seoul National University (KR)
- Gyeongsang National University (KR)
- Eulji University (KR)
- Asan Medical Center (KR)
- Seoul National University Hospital (KR)
- University of Ulsan (KR)
- Gyeongsang National University Hospital (KR)
Publication Details
- Journal
- Therapeutic Advances in Psychopharmacology
- Published
- 2025-04-22
- DOI
- https://doi.org/10.1177/20451253251333987
- Citations
- 2
- Primary Topic
- Schizophrenia research and treatment
- Type
- article
- Field-Weighted Citation Impact
- 2.94
Funders
- Janssen Pharmaceuticals